• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于去卷积的非参数个体特异性总体方法:I. 描述、内部验证及实际数据示例

A nonparametric subject-specific population method for deconvolution: I. Description, internal validation, and real data examples.

作者信息

Fattinger K E, Verotta D

机构信息

Department of Pharmacy and Pharmaceutical Chemistry, University of California San Francisco 94143, USA.

出版信息

J Pharmacokinet Biopharm. 1995 Dec;23(6):581-610. doi: 10.1007/BF02353463.

DOI:10.1007/BF02353463
PMID:8733948
Abstract

In a pharmacokinetics context deconvolution facilitates the following: (i) Given data obtained after intravascular (generally intravenous) input one may estimate the disposition function; (ii) given the disposition function and data obtained after extravascular administration one may estimate the extravascular to vascular input rate function. In general if the data can be represented by the convolution of two functions, of which one is unknown, deconvolution allows the estimation of the unknown one. Attention has been given in the past to deconvolution and in particular to its nonparametric variants. However, in a population context (multiple observations collected in each of a group of subjects) the use of nonparametric deconvolution is limited to either analyzing each subject separately or to analyzing the aggregate response from the population without specifying subject-specific characteristics. To our knowledge a fully nonparametric deconvolution method in which subject specificity is explicitly taken into account has not been reported. To do so we use so-called "longitudinal splines." A longitudinal spline is a nonparametric function composed of a template spline, in common to all subjects, and of a distortion spline representing the difference of the subject's function from the template. Using longitudinal splines for input rate or disposition function one obtains a solution to the problem of taking subject specificity into account in a nonparametric deconvolution context. To obtain estimates of longitudinal splines we consider three different methods: (1) parametric nonlinear mixed effect, (2) least squares, and (3) two-stage. Results obtained in one simulated and two real data analyses are shown.

摘要

在药代动力学背景下,反卷积有助于以下几点:(i) 给定血管内(通常为静脉内)输入后获得的数据,可以估计处置函数;(ii) 给定处置函数和血管外给药后获得的数据,可以估计血管外到血管的输入速率函数。一般来说,如果数据可以由两个函数的卷积表示,其中一个是未知的,反卷积可以估计未知的那个函数。过去人们已经关注到反卷积,特别是其非参数变体。然而,在群体背景下(在一组受试者中的每一个受试者上收集多个观察值),非参数反卷积的使用仅限于分别分析每个受试者,或者在不指定受试者特异性特征的情况下分析群体的总体反应。据我们所知,尚未报道一种明确考虑受试者特异性的完全非参数反卷积方法。为此,我们使用所谓的“纵向样条”。纵向样条是一种非参数函数,由所有受试者共有的模板样条和表示受试者函数与模板差异的变形样条组成。使用纵向样条来估计输入速率或处置函数,可以在非参数反卷积背景下解决考虑受试者特异性的问题。为了获得纵向样条的估计值,我们考虑三种不同的方法:(1) 参数非线性混合效应,(2) 最小二乘法,以及(3) 两阶段法。展示了在一次模拟分析和两次真实数据分析中获得的结果。

相似文献

1
A nonparametric subject-specific population method for deconvolution: I. Description, internal validation, and real data examples.一种用于去卷积的非参数个体特异性总体方法:I. 描述、内部验证及实际数据示例
J Pharmacokinet Biopharm. 1995 Dec;23(6):581-610. doi: 10.1007/BF02353463.
2
A nonparametric subject-specific population method for deconvolution: II. External validation.一种用于去卷积的非参数个体特异性总体方法:II. 外部验证。
J Pharmacokinet Biopharm. 1995 Dec;23(6):611-34. doi: 10.1007/BF02353464.
3
An inequality-constrained least-squares deconvolution method.一种不等式约束最小二乘反褶积方法。
J Pharmacokinet Biopharm. 1989 Apr;17(2):269-89. doi: 10.1007/BF01059031.
4
Volterra series in pharmacokinetics and pharmacodynamics.药代动力学和药效学中的沃尔泰拉级数
J Pharmacokinet Pharmacodyn. 2003 Oct;30(5):337-62. doi: 10.1023/b:jopa.0000008158.30235.59.
5
Two constrained deconvolution methods using spline functions.两种使用样条函数的约束反卷积方法。
J Pharmacokinet Biopharm. 1993 Oct;21(5):609-36. doi: 10.1007/BF01059117.
6
Deconvolution Analysis by Non-linear Regression Using a Convolution-Based Model: Comparison of Nonparametric and Parametric Approaches.基于卷积模型的非线性回归解卷积分析:非参数和参数方法的比较。
AAPS J. 2019 Dec 9;22(1):9. doi: 10.1208/s12248-019-0389-8.
7
DeMonS--a new deconvolution method for estimating drug absorbed at different time intervals and/or drug disposition model parameters using a monotonic cubic spline.DeMonS——一种使用单调三次样条估计不同时间间隔吸收的药物和/或药物处置模型参数的新去卷积方法。
Biopharm Drug Dispos. 1997 Aug;18(6):475-87. doi: 10.1002/(sici)1099-081x(199708)18:6<475::aid-bdd33>3.0.co;2-4.
8
Estimation and model selection in constrained deconvolution.约束反卷积中的估计与模型选择
Ann Biomed Eng. 1993 Nov-Dec;21(6):605-20. doi: 10.1007/BF02368641.
9
Stepwise determination of multicompartment disposition and absorption parameters from extravascular concentration-time data. Application to mesoridazine, flurbiprofen, flunarizine, labetalol, and diazepam.从血管外浓度-时间数据逐步确定多室处置和吸收参数。应用于甲砜哒嗪、氟比洛芬、氟桂利嗪、拉贝洛尔和地西泮。
J Pharmacokinet Biopharm. 1991 Aug;19(4):413-55. doi: 10.1007/BF01061665.
10
Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies.参数和非参数总体方法:它们在分析临床数据集和两项蒙特卡罗模拟研究中的比较性能。
Clin Pharmacokinet. 2006;45(4):365-83. doi: 10.2165/00003088-200645040-00003.

引用本文的文献

1
Estimation of parameters for the elimination of an orally administered test substance with unknown absorption.口服未知吸收试验物质消除的参数估计。
J Pharmacokinet Pharmacodyn. 2013 Apr;40(2):177-87. doi: 10.1007/s10928-013-9299-z. Epub 2013 Feb 2.
2
Oral heroin in opioid-dependent patients: pharmacokinetic comparison of immediate and extended release tablets.阿片类药物依赖患者口服海洛因:速释片与缓释片的药代动力学比较
Eur J Pharm Sci. 2009 Mar 2;36(4-5):421-32. doi: 10.1016/j.ejps.2008.11.008. Epub 2008 Nov 25.
3
Population pharmacokinetic modelling of the enterohepatic recirculation of diclofenac and rofecoxib in rats.

本文引用的文献

1
A nonparametric subject-specific population method for deconvolution: II. External validation.一种用于去卷积的非参数个体特异性总体方法:II. 外部验证。
J Pharmacokinet Biopharm. 1995 Dec;23(6):611-34. doi: 10.1007/BF02353464.
2
Two constrained deconvolution methods using spline functions.两种使用样条函数的约束反卷积方法。
J Pharmacokinet Biopharm. 1993 Oct;21(5):609-36. doi: 10.1007/BF01059117.
3
Estimation and model selection in constrained deconvolution.约束反卷积中的估计与模型选择
双氯芬酸和罗非昔布在大鼠体内肠肝循环的群体药代动力学建模
Br J Pharmacol. 2008 Mar;153(5):1072-84. doi: 10.1038/sj.bjp.0707643. Epub 2008 Jan 14.
4
Reversible jump Markov chain Monte Carlo for deconvolution.用于反卷积的可逆跳跃马尔可夫链蒙特卡罗方法
J Pharmacokinet Pharmacodyn. 2007 Jun;34(3):263-87. doi: 10.1007/s10928-006-9045-x. Epub 2007 Jan 13.
5
Application of SPLINDID, a semiparametric, model-based method for pharmacogenomic modeling of mRNA dynamics.SPLINDID(一种基于模型的半参数方法)在mRNA动力学药物基因组学建模中的应用。
Pharm Res. 2006 Apr;23(4):663-9. doi: 10.1007/s11095-006-9747-1. Epub 2006 Mar 24.
6
The use of a sum of inverse Gaussian functions to describe the absorption profile of drugs exhibiting complex absorption.使用一组逆高斯函数来描述具有复杂吸收特性的药物的吸收曲线。
Pharm Res. 2005 Aug;22(8):1227-35. doi: 10.1007/s11095-005-5266-8. Epub 2005 Aug 3.
7
Biomarkers, validation and pharmacokinetic-pharmacodynamic modelling.生物标志物、验证及药代动力学-药效学建模
Clin Pharmacokinet. 2003;42(12):997-1022. doi: 10.2165/00003088-200342120-00001.
8
Influence of arterial vs. venous sampling site on nicotine tolerance model selection and parameter estimation.动脉与静脉采血部位对尼古丁耐受模型选择及参数估计的影响。
J Pharmacokinet Pharmacodyn. 2002 Feb;29(1):49-66. doi: 10.1023/a:1015768602037.
9
Use of a pharmacokinetic/pharmacodynamic model to design an optimal dose input profile.
J Pharmacokinet Biopharm. 1998 Aug;26(4):471-92. doi: 10.1023/a:1021068202606.
10
A semiparametric method for describing noisy population pharmacokinetic data.
J Pharmacokinet Biopharm. 1997 Oct;25(5):615-42. doi: 10.1023/a:1025769431364.
Ann Biomed Eng. 1993 Nov-Dec;21(6):605-20. doi: 10.1007/BF02368641.
4
Estimating bioavailability when clearance varies with time.
Clin Pharmacol Ther. 1994 Jun;55(6):623-37. doi: 10.1038/clpt.1994.79.
5
Estimating bioavailability when clearance changes in time: the effect of model misspecification.
Clin Pharmacol Ther. 1995 Nov;58(5):595-600. doi: 10.1016/0009-9236(95)90181-7.
6
Evaluation of methods for estimating population pharmacokinetic parameters. II. Biexponential model and experimental pharmacokinetic data.群体药代动力学参数估计方法的评估。II. 双指数模型与实验药代动力学数据
J Pharmacokinet Biopharm. 1981 Oct;9(5):635-51. doi: 10.1007/BF01061030.
7
Random-effects models for longitudinal data.纵向数据的随机效应模型。
Biometrics. 1982 Dec;38(4):963-74.
8
Population pharmacokinetic data and parameter estimation based on their first two statistical moments.基于前两个统计矩的群体药代动力学数据和参数估计。
Drug Metab Rev. 1984;15(1-2):173-93. doi: 10.3109/03602538409015064.
9
The population approach to pharmacokinetic data analysis: rationale and standard data analysis methods.药代动力学数据分析的群体方法:原理与标准数据分析方法
Drug Metab Rev. 1984;15(1-2):153-71. doi: 10.3109/03602538409015063.
10
The theory of least squares when the parameters are stochastic and its application to the analysis of growth curves.参数为随机变量时的最小二乘法理论及其在生长曲线分析中的应用。
Biometrika. 1965 Dec;52(3):447-58.